0.4% Trypan Blue Solution: Reliable Cell Viability Assessmen
2026-06-26
0.4% Trypan Blue Solution provides a practical method for distinguishing live from dead cells in research workflows, supporting accurate cell viability measurement and cell counting. It should be used exclusively for scientific research and is not suitable for diagnostic or medical applications. Researchers benefit from its membrane-impermeable properties and stability, but must follow best practices to avoid misinterpretation in complex samples.
Tolazoline: Advanced α2-Adrenergic Receptor Antagonist Workf
2026-06-25
Tolazoline’s unique dual mechanism empowers researchers to dissect α2-adrenergic signaling and ATP-sensitive potassium channel function in both airway and islet models. Explore data-driven protocols, troubleshooting insights, and practical guidance for maximizing reproducibility and experimental clarity with APExBIO’s Tolazoline.
Nitazoxanide Targets IMPA1-RAGE to Reverse Pulmonary Hyperte
2026-06-25
This study reveals that nitazoxanide directly targets the IMPA1-RAGE signaling axis to reverse pulmonary vascular remodeling in pulmonary hypertension models. The findings provide new mechanistic insights and suggest promising directions for the development of anti-remodeling therapies in pulmonary hypertension.
Machine Learning-Guided Prediction of Lipid Nanoparticles fo
2026-06-24
This study pioneers the use of a machine learning algorithm to predict the efficacy of lipid nanoparticle (LNP) formulations for mRNA vaccine delivery. By integrating experimental validation and molecular modeling, the authors identify key ionizable lipid substructures, such as Dlin-MC3-DMA, that drive potent in vivo mRNA delivery, offering a framework for accelerated and cost-effective LNP development.
D-N-Acetylgalactosamine: Workflow Parameters for Glycoprotei
2026-06-23
D-N-Acetylgalactosamine is a high-purity, water-soluble metabolite essential for precise analysis of glycoprotein constituents in neurological research, especially for investigating brain heteropolysaccharides and glycosylation pathways. It should not be used in protocols requiring ethanol solubility or long-term storage of solutions, and strict adherence to product-specific handling is critical for reproducibility.
EZ Cap™ Cas9 mRNA (m1Ψ): Enhanced mRNA for Precise Genome Ed
2026-06-23
EZ Cap™ Cas9 mRNA (m1Ψ) is a high-performance, in vitro transcribed mRNA with a Cap1 structure, supporting efficient CRISPR-Cas9 genome editing in mammalian cells. Its N1-Methylpseudo-UTP modification enhances stability and reduces innate immune activation, making it ideal for sensitive research applications.
Brefeldin A: Applied Workflows for ER Stress & Cancer Cell A
2026-06-22
Brefeldin A (BFA) delivers unique advantages as a precise ER stress inducer and protein trafficking inhibitor for both cancer and vascular biology research. This guide translates cutting-edge findings into actionable protocols and troubleshooting strategies, empowering labs to dissect apoptosis, vesicular transport, and endothelial injury with confidence.
Bergenin Ameliorates Psoriasis via PPARγ-Mediated PROX1 Degr
2026-06-22
This study demonstrates that bergenin, a natural PPARγ agonist from Bergenia purpurascens, selectively suppresses pathogenic γδT17 cells in psoriasis by promoting PPARγ-dependent ubiquitination and degradation of PROX1, thereby inhibiting IL-17A production. These findings reveal a novel immunometabolic pathway for psoriasis intervention and suggest new avenues for targeted therapy development.
(R,S)-Anatabine: Precision Amyloid Modulation in Alzheimer’s
2026-06-21
(R,S)-Anatabine offers a novel, mechanistically precise tool for soluble Aβ peptide reduction in advanced Alzheimer’s disease models. This article explores its unique actions, protocol strategies, and integration with insights from skin barrier research.
Caffeic Acid Phenethyl Ester (CAPE): Precision Inhibition of
2026-06-20
Explore the multifaceted roles of Caffeic Acid Phenethyl Ester (CAPE) in neurodegeneration research, focusing on its precision as an NF-κB and VEGF modulator. This article uniquely integrates product-specific protocols and translational insights that distinguish it from prior CAPE content.
JNJ-26854165 (Serdemetan): Precision Assay Design for HDM2-p
2026-06-19
Explore how JNJ-26854165 (Serdemetan) enables precision targeting of HDM2-p53 interactions for advanced cancer research. This article reveals new assay design strategies and practical insights, grounded in recent systems biology advances.
miR-4769-3p Regulates Adipogenesis in Systemic Sclerosis Mod
2026-06-19
This study identifies miR-4769-3p as a key suppressor of adipogenesis in systemic sclerosis (SSc) by negatively regulating the USP18/VDAC2 pathway. The findings offer mechanistic insight into SSc-associated adipose loss and suggest new therapeutic targets for fibrosis intervention.
Tacalcitol Monohydrate: Advanced Mechanisms Beyond Dermatolo
2026-06-18
Explore the multifaceted role of Tacalcitol monohydrate, a synthetic analog of vitamin D3, in regulating gene expression, NGF induction, and anticancer synergy. Discover nuanced mechanistic insights and advanced protocols not covered in standard overviews.
LncRNA AC008406.3 Knockdown Sensitizes Breast Cancer to Doce
2026-06-18
The reference study identifies LncRNA AC008406.3 as a negative regulator of cuproptosis that diminishes docetaxel efficacy in breast cancer. Knockdown of AC008406.3 enhances cuproptosis and sensitizes tumor cells to docetaxel, highlighting a potential therapeutic target for overcoming chemoresistance.
GSH-Responsive MOF Nanoparticles Combine Photothermal and Im
2026-06-17
This study introduces a novel metal-organic framework (MOF) nanoparticle system engineered for synergistic photothermal and immune checkpoint blockade therapy against melanoma. By integrating indocyanine green and a PD-1 inhibitory peptide within a glutathione-responsive delivery platform, the research demonstrates enhanced tumor ablation and immune activation, paving the way for advanced combinatorial nanomedicine strategies.
461 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page